<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8302946</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4093</journal-id>
<journal-id journal-id-type="nlm-ta">Hepatology</journal-id>
<journal-id journal-id-type="iso-abbrev">Hepatology</journal-id>
<journal-title-group>
<journal-title>Hepatology (Baltimore, Md.)</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-9139</issn>
<issn pub-type="epub">1527-3350</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30230575</article-id>
<article-id pub-id-type="pmc">6393921</article-id>
<article-id pub-id-type="doi">10.1002/hep.30284</article-id>
<article-id pub-id-type="manuscript">NIHMS989673</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>UBE3A suppresses overnutrition-induced expression of the steatosis
target genes of MLL4 by degrading MLL4</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Kim</surname>
<given-names>Janghyun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Lee</surname>
<given-names>Bora</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Dae-Hwan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yeon</surname>
<given-names>Je Gwang</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Jeongkyung</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Younjung</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Yuna</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Soo-Kyung</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Seunghee</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Jae W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Neuroscience Section, Papé Family Pediatric Research
Institute, Department of Pediatrics, Oregon Health &amp; Science University,
Portland, OR 97239, USA</aff>
<aff id="A2"><label>2</label>Center for Neuroscience, Korea Institute of Science and
Technology, Seoul 02792, Korea</aff>
<aff id="A3"><label>3</label>College of Pharmacy and Research Institute of
Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea</aff>
<aff id="A4"><label>4</label>Division of Endocrinology &amp; Metabolism, Department of
Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA</aff>
<aff id="A5"><label>5</label>Vollum Institute, Oregon Health &amp; Science University,
Portland, OR 97239, USA</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Correspondences: Seunghee Lee
(<email>leeseung@snu.ac.kr</email>) or Jae W. Lee
(<email>leejae@ohsu.edu</email>)</corresp>
<fn fn-type="con" id="FN1">
<p id="P1">Author contributions</p>
<p id="P2">J.K., B.L., D.H.K., Y.P., Y.L., J.G.Y., and J.K.L. conducted the
experiments, S.L. and J.W.L. designed the experiments, and S.L., S.K.L. and
J.W.L. wrote the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2020</year>
</pub-date>
<volume>69</volume>
<issue>3</issue>
<fpage>1122</fpage>
<lpage>1134</lpage>
<!--elocation-id from pubmed: 10.1002/hep.30284-->
<abstract id="ABS1">
<p id="P3">Regulation of the protein stability of epigenetic regulators remains
ill-defined despite its potential applicability in epigenetic therapies. The
histone H3-lysine 4-methyltransferase MLL4 is an epigenetic transcriptional
coactivator that directs overnutrition-induced obesity and fatty liver
formation, and <italic>Mll4</italic><sup><italic>+/−</italic></sup> mice
are resistant to both. Here we show that the E3 ubiquitin ligase UBE3A targets
MLL4 for degradation thereby suppressing high fat diet (HFD)-induced expression
of the hepatic steatosis target genes of MLL4. In contrast to
<italic>Mll4</italic><sup><italic>+/−</italic></sup> mice,
<italic>Ube3a</italic><sup><italic>+/−</italic></sup> mice are
hypersensitive to HFD-induced obesity and fatty liver development.
<italic>Ube3a</italic><sup><italic>+/−</italic></sup><italic>;Mll4</italic><sup><italic>+/−</italic></sup>
mice lose this hypersensitivity, supporting roles of increased MLL4 levels in
both phenotypes of <italic>Ube3a</italic><sup><italic>+/−</italic></sup>
mice. Correspondingly, our comparative studies with wild-type,
<italic>Ube3a</italic><sup><italic>+/−</italic></sup> and
<italic>Ube3a</italic><sup><italic>−/−</italic></sup> and
UBE3A-overexpressing transgenic mouse livers demonstrate inverse-correlation of
UBE3A protein levels with MLL4 protein levels, expression of the steatosis
target genes of MLL4, and their decoration by H3-lysine 4-monomethylation, a
surrogate marker for the epigenetic action of MLL4. Therefore, UBE3A indirectly
exerts an epigenetic regulation of obesity and steatosis by degrading MLL4. This
UBE3A-MLL4 regulatory axis provides a potential therapeutic venue for treating
various MLL4-directed pathogeneses, including obesity and hepatic steatosis.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>